Username


Password

Preview

Sandor Batkai

Publications

  • TOP 3
  • Sándor Bátkai; Partha Mukhopadhyay; Bėla Horváth; Mohanraj Rajesh; Rachel Y Gao; Anu Mahadevan; Mukkanti Amere; Natalia Battista; Aron H Lichtman; Lisa A Gauson; et al.
    Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
  • Bėla Horváth; Lital Magid; Partha Mukhopadhyay; Sándor Bátkai; Mohanraj Rajesh; Ogyi Park; Galin Tanchian; Rachel Y Gao; Catherine E Goodfellow; Michelle Glass; et al.
    A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
  • Mohanraj Rajesh; Sándor Bátkai; Malek Kechrid; Partha Mukhopadhyay; Wen-Shin Lee; Béla Horváth; Eileen Holovac; Resat Cinar; Lucas Liaudet; Ken Mackie; et al.
    Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
Register to see all publications

Register for free to view:

Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the research activity
of experts around the globe
Register to see more

Geonetwork of Sandor Batkai (preview)

  • Cities where this author has publications
  • Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

  • 2012: Sándor Bátkai; Partha Mukhopadhyay; Bėla Horváth; Mohanraj Rajesh; Rachel Y Gao; Anu Mahadevan; Mukkanti Amere; Natalia Battista; Aron H Lichtman; Lisa A Gauson; et al.
    Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
    British journal of pharmacology 2012;165(8):2450-61.
  • 2012: Bėla Horváth; Lital Magid; Partha Mukhopadhyay; Sándor Bátkai; Mohanraj Rajesh; Ogyi Park; Galin Tanchian; Rachel Y Gao; Catherine E Goodfellow; Michelle Glass; et al.
    A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
    British journal of pharmacology 2012;165(8):2462-78.
  • 2012: Mohanraj Rajesh; Sándor Bátkai; Malek Kechrid; Partha Mukhopadhyay; Wen-Shin Lee; Béla Horváth; Eileen Holovac; Resat Cinar; Lucas Liaudet; Ken Mackie; et al.
    Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
    Diabetes 2012;61(3):716-27.
  • 2012: Alexander A Zoerner; Christin Rakers; Stefan Engeli; Sandor Batkai; Marcus May; Jens Jordan; Dimitrios Tsikas
    Peripheral endocannabinoid microdialysis: in vitro characterization and proof-of-concept in human subjects.
    Analytical and bioanalytical chemistry 2012;402(9):2727-35.
  • 2012: Christin Rakers; Alexander A Zoerner; Stefan Engeli; Sandor Batkai; Jens Jordan; Dimitrios Tsikas
    Stable isotope liquid chromatography-tandem mass spectrometry assay for fatty acid amide hydrolase activity.
    Analytical biochemistry 2012;421(2):699-705.
  • 2012: Alexander A Zoerner; Sandor Batkai; Maria-Theresia Suchy; Frank-Mathias Gutzki; Stefan Engeli; Jens Jordan; Dimitrios Tsikas
    Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2012;883-884():161-71.
  • 2011: Alexander A Zoerner; Frank-Mathias Gutzki; Sandor Batkai; Marcus May; Christin Rakers; Stefan Engeli; Jens Jordan; Dimitrios Tsikas
    Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective.
    Biochimica et biophysica acta 2011;1811(11):706-23.
  • 2011: A A Zoerner; D O Stichtenoth; S Engeli; S Batkai; C Winkler; F Schaumann; J Janke; O Holz; N Krug; D Tsikas; et al.
    Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma.
    Clinical pharmacology and therapeutics 2011;90(3):388-91.
  • 2011: Partha Mukhopadhyay; Mohanraj Rajesh; Béla Horváth; Sándor Bátkai; Ogyi Park; Galin Tanchian; Rachel Y Gao; Vivek Patel; David A Wink; Lucas Liaudet; et al.
    Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
    Free radical biology & medicine 2011;50(10):1368-81.
  • 2011: Partha Mukhopadhyay; Bėla Horváth; Mohanraj Rajesh; Shingo Matsumoto; Keita Saito; Sándor Bátkai; Vivek Patel; Galin Tanchian; Rachel Y Gao; Benjamin F Cravatt; et al.
    Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.
    Free radical biology & medicine 2011;50(1):179-95.
  • 2010: Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; Vivek Patel; Keita Saito; Shingo Matsumoto; Yoshihiro Kashiwaya; Béla Horváth; Bani Mukhopadhyay; Lauren Becker; et al.
    Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
    Journal of the American College of Cardiology 2010;56(25):2115-25.
  • 2010: Grzegorz Godlewski; Shakiru O Alapafuja; Sándor Bátkai; Spyros P Nikas; Resat Cinar; László Offertáler; Douglas Osei-Hyiaman; Jie Liu; Bani Mukhopadhyay; Judith Harvey-White; et al.
    Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.
    Chemistry & biology 2010;17(11):1256-66.
  • 2010: R Jumpertz; T Wiesner; M Blüher; S Engeli; S Bátkai; H Wirtz; A Bosse-Henck; M Stumvoll
    Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2010;118(9):591-5.
  • 2010: Thomas Thum; Sandor Batkai; Philipp G Malinski; Thomas Becker; Iris Mevius; Jürgen Klempnauer; Hartmut H Meyer; Jürgen C Frölich; Jürgen Borlak; Dimitrios Tsikas
    Measurement and diagnostic use of hepatic cytochrome P450 metabolism of oleic acid in liver disease.
    Liver international : official journal of the International Association for the Study of the Liver 2010;30(8):1181-8.
  • 2010: Partha Mukhopadhyay; Hao Pan; Mohanraj Rajesh; Sándor Bátkai; Vivek Patel; Judith Harvey-White; Bani Mukhopadhyay; György Haskó; Bin Gao; Ken Mackie; et al.
    CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.
    British journal of pharmacology 2010;160(3):657-68.
  • 2010: Partha Mukhopadhyay; Mohanraj Rajesh; Hao Pan; Vivek Patel; Bani Mukhopadhyay; Sándor Bátkai; Bin Gao; György Haskó; Pál Pacher
    Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.
    Free radical biology & medicine 2010;48(3):457-67.
  • 2009: Christoph Schroeder; Sandor Batkai; Stefan Engeli; Jens Tank; André Diedrich; Friedrich C Luft; Jens Jordan
    Circulating endocannabinoid concentrations during orthostatic stress.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2009;19(6):343-6.
  • 2009: Sándor Bátkai; Pál Pacher
    Endocannabinoids and cardiac contractile function: pathophysiological implications.
    Pharmacological research : the official journal of the Italian Pharmacological Society 2009;60(2):99-106.
  • 2009: Partha Mukhopadhyay; Mohanraj Rajesh; Sándor Bátkai; Yoshihiro Kashiwaya; György Haskó; Lucas Liaudet; Csaba Szabó; Pál Pacher
    Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
    American journal of physiology. Heart and circulatory physiology 2009;296(5):H1466-83.
  • 2009: George Kunos; Douglas Osei-Hyiaman; Sándor Bátkai; Keith A Sharkey; Alexandros Makriyannis
    Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?
    Trends in pharmacological sciences 2009;30(1):1-7.
  • 2008: George Kunos; Douglas Osei-Hyiaman; Jie Liu; Gregorz Godlewski; Sándor Bátkai
    Endocannabinoids and the control of energy homeostasis.
    The Journal of biological chemistry 2008;283(48):33021-5.
  • 2008: Pál Pacher; Partha Mukhopadhyay; Rajesh Mohanraj; Grzegorz Godlewski; Sándor Bátkai; George Kunos
    Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations.
    Hypertension 2008;52(4):601-7.
  • 2008: Douglas Osei-Hyiaman; Jie Liu; Liang Zhou; Grzegorz Godlewski; Judith Harvey-White; Won-il Jeong; Sándor Bátkai; Giovanni Marsicano; Beat Lutz; Christoph Buettner; et al.
    Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.
    The Journal of clinical investigation 2008;118(9):3160-9.
  • 2008: Stefan Engeli; Karsten Heusser; Jürgen Janke; Kerstin Gorzelniak; Sándor Bátkai; Pál Pacher; Judith Harvey-White; Friedrich C Luft; Jens Jordan
    Peripheral endocannabinoid system activity in patients treated with sibutramine.
    Obesity (Silver Spring, Md.) 2008;16(5):1135-7.
  • 2008: Won-il Jeong; Douglas Osei-Hyiaman; Ogyi Park; Jie Liu; Sándor Bátkai; Partha Mukhopadhyay; Norio Horiguchi; Judith Harvey-White; Giovanni Marsicano; Beat Lutz; et al.
    Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
    Cell metabolism 2008;7(3):227-35.
  • 2008: Christoph W Michalski; Florian E Oti; Mert Erkan; Danguole Sauliunaite; Frank Bergmann; Pal Pacher; Sandor Batkai; Michael W Müller; Nathalia A Giese; Helmut Friess; et al.
    Cannabinoids in pancreatic cancer: correlation with survival and pain.
    International journal of cancer. Journal international du cancer 2008;122(4):742-50.
  • 2008: Pál Pacher; Takahiro Nagayama; Partha Mukhopadhyay; Sándor Bátkai; David A Kass
    Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats.
    Nature protocols 2008;3(9):1422-34.
  • 2008: Christoph W Michalski; Milena Maier; Mert Erkan; Danguole Sauliunaite; Frank Bergmann; Pal Pacher; Sandor Batkai; Nathalia A Giese; Thomas Giese; Helmut Friess; et al.
    Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells.
    PloS one 2008;3(2):e1701.
  • 2007: Mohanraj Rajesh; Hao Pan; Partha Mukhopadhyay; Sándor Bátkai; Douglas Osei-Hyiaman; György Haskó; Lucas Liaudet; Bin Gao; Pál Pacher
    Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis.
    Journal of leukocyte biology 2007;82(6):1382-9.
  • 2007: Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; György Haskó; Lucas Liaudet; John W Huffman; Anna Csiszar; Zoltan Ungvari; Ken Mackie; Subroto Chatterjee; et al.
    CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.
    American journal of physiology. Heart and circulatory physiology 2007;293(4):H2210-8.
  • 2007: Sándor Bátkai; Partha Mukhopadhyay; Judith Harvey-White; Raouf Kechrid; Pál Pacher; George Kunos
    Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.
    American journal of physiology. Heart and circulatory physiology 2007;293(3):H1689-95.
  • 2007: Partha Mukhopadhyay; Sándor Bátkai; Mohanraj Rajesh; Nora Czifra; Judith Harvey-White; György Haskó; Zsuzsanna Zsengeller; Norma P Gerard; Lucas Liaudet; George Kunos; et al.
    Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.
    Journal of the American College of Cardiology 2007;50(6):528-36.
  • 2007: Sándor Bátkai; Mohanraj Rajesh; Partha Mukhopadhyay; György Haskó; Lucas Liaudet; Benjamin F Cravatt; Anna Csiszár; Zoltan Ungvári; Pál Pacher
    Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.
    American journal of physiology. Heart and circulatory physiology 2007;293(2):H909-18.
  • 2007: Nitin Agarwal; Pal Pacher; Irmgard Tegeder; Fumimasa Amaya; Cristina E Constantin; Gary J Brenner; Tiziana Rubino; Christoph W Michalski; Giovanni Marsicano; Krisztina Monory; et al.
    Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.
    Nature neuroscience 2007;10(7):870-9.
  • 2007: Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; György Haskó; Lucas Liaudet; Viktor R Drel; Irina G Obrosova; Pál Pacher
    Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.
    American journal of physiology. Heart and circulatory physiology 2007;293(1):H610-9.
  • 2007: Sándor Bátkai; Douglas Osei-Hyiaman; Hao Pan; Osama El-Assal; Mohanraj Rajesh; Partha Mukhopadhyay; Feng Hong; Judith Harvey-White; Anjum Jafri; György Haskó; et al.
    Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(8):1788-800.
  • 2007: Christoph W Michalski; Tamara Laukert; Danguole Sauliunaite; Pál Pacher; Frank Bergmann; Nitin Agarwal; Yun Su; Thomas Giese; Nathalia A Giese; Sándor Bátkai; et al.
    Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
    Gastroenterology 2007;132(5):1968-78.
  • 2006: Mohanraj Rajesh; Partha Mukhopadhyay; Grzegorz Godlewski; Sándor Bátkai; György Haskó; Lucas Liaudet; Pál Pacher
    Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.
    Biochemical and biophysical research communications 2006;350(4):1056-62.
  • 2006: Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; Grzegorz Godlewski; György Haskó; Lucas Liaudet; Pál Pacher
    Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis.
    Biochemical and biophysical research communications 2006;350(2):352-7.
  • 2006: Matthias Blüher; Stefan Engeli; Nora Klöting; Janin Berndt; Mathias Fasshauer; Sándor Bátkai; Pál Pacher; Michael R Schön; Jens Jordan; Michael Stumvoll
    Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.
    Diabetes 2006;55(11):3053-60.
  • 2006: Pál Pacher; Sándor Bátkai; George Kunos
    The endocannabinoid system as an emerging target of pharmacotherapy.
    Pharmacological reviews 2006;58(3):389-462.
  • 2006: George Kunos; Douglas Osei-Hyiaman; Sándor Bátkai; Bin Gao
    Cannabinoids hurt, heal in cirrhosis.
    Nature medicine 2006;12(6):608-10.
  • 2006: Richard Young; Sandor Batkai; Malgorzata Dukat; Richard A Glennon
    TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice.
    Pharmacology, biochemistry, and behavior 2006;84(1):62-73.
  • 2006: D Osei-Hyiaman; J Harvey-White; S Bátkai; G Kunos
    The role of the endocannabinoid system in the control of energy homeostasis.
    International journal of obesity (2005) 2006;30 Suppl 1():S33-8.
  • 2006: Garry Milman; Yehoshua Maor; Saleh Abu-Lafi; Michal Horowitz; Ruth Gallily; Sandor Batkai; Fong-Ming Mo; Laszlo Offertaler; Pal Pacher; George Kunos; et al.
    N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties.
    Proceedings of the National Academy of Sciences of the United States of America 2006;103(7):2428-33.
  • 2005: Stefan Engeli; Jana Böhnke; Mareike Feldpausch; Kerstin Gorzelniak; Jürgen Janke; Sándor Bátkai; Pál Pacher; Judy Harvey-White; Friedrich C Luft; Arya M Sharma; et al.
    Activation of the peripheral endocannabinoid system in human obesity.
    Diabetes 2005;54(10):2838-43.
  • 2005: Pál Pacher; Sándor Bátkai; George Kunos
    Cirrhotic cardiomyopathy: an endocannabinoid connection?
    British journal of pharmacology 2005;146(3):313-4.
  • 2005: Pál Pacher; Sándor Bátkai; Douglas Osei-Hyiaman; László Offertáler; Jie Liu; Judy Harvey-White; Attila Brassai; Zoltán Járai; Benjamin F Cravatt; George Kunos
    Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
    American journal of physiology. Heart and circulatory physiology 2005;289(2):H533-41.
  • 2005: Zoltan Ungvári; Sachin A Gupte; Fabio A Recchia; Sándor Bátkai; Pál Pacher
    Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.
    Current vascular pharmacology 2005;3(3):221-9.
  • 2005: Pál Pacher; Sándor Bátkai; George Kunos
    Blood pressure regulation by endocannabinoids and their receptors.
    Neuropharmacology 2005;48(8):1130-8.
  • 2005: Malcolm Begg; Pál Pacher; Sándor Bátkai; Douglas Osei-Hyiaman; László Offertáler; Fong Ming Mo; Jie Liu; George Kunos
    Evidence for novel cannabinoid receptors.
    Pharmacology & therapeutics 2005;106(2):133-45.
  • 2005: Douglas Osei-Hyiaman; Michael DePetrillo; Pál Pacher; Jie Liu; Svetlana Radaeva; Sándor Bátkai; Judith Harvey-White; Ken Mackie; László Offertáler; Lei Wang; et al.
    Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.
    The Journal of clinical investigation 2005;115(5):1298-305.
  • 2005: P Pacher; S Bátkai; G Kunos
    Cardiovascular pharmacology of cannabinoids.
    Handbook of experimental pharmacology 2005;(168):599-625.
  • 2004: Pál Pacher; Anne Vaslin; Rita Benko; Jon G Mabley; Lucas Liaudet; György Haskó; Anita Marton; Sándor Bátkai; Márk Kollai; Csaba Szabó
    A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging.
    The Journal of pharmacology and experimental therapeutics 2004;311(2):485-91.
  • 2004: Sándor Bátkai; Pál Pacher; Douglas Osei-Hyiaman; Svetlana Radaeva; Jie Liu; Judith Harvey-White; László Offertáler; Ken Mackie; M Audrey Rudd; Richard D Bukoski; et al.
    Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
    Circulation 2004;110(14):1996-2002.
  • 2004: Sándor Bátkai; Pál Pacher; Zoltán Járai; Jens A Wagner; George Kunos
    Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors.
    American journal of physiology. Heart and circulatory physiology 2004;287(2):H595-600.
  • 2004: Pál Pacher; Sándor Bátkai; George Kunos
    Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice.
    The Journal of physiology 2004;558(Pt 2):647-57.
  • 2003: Malcolm Begg; Fong-Ming Mo; László Offertaler; Sándor Bátkai; Pál Pacher; Raj K Razdan; David M Lovinger; George Kunos
    G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current.
    The Journal of biological chemistry 2003;278(46):46188-94.
  • 2003: Jie Liu; Sándor Batkai; Pál Pacher; Judith Harvey-White; Jens A Wagner; Benjamin F Cravatt; Bin Gao; George Kunos
    Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor.
    The Journal of biological chemistry 2003;278(45):45034-9.
  • 2003: Zhaoli Sun; Andrew S Klein; Svetlana Radaeva; Feng Hong; Osama El-Assal; Hong-Na Pan; Barbara Jaruga; Sandor Batkai; Sumito Hoshino; Zhigang Tian; et al.
    In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.
    Gastroenterology 2003;125(1):202-15.
  • 2003: László Offertáler; Fong-Ming Mo; Sándor Bátkai; Jie Liu; Malcolm Begg; Raj K Razdan; Billy R Martin; Richard D Bukoski; George Kunos
    Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.
    Molecular pharmacology 2003;63(3):699-705.
  • 2002: George Kunos; Sándor Bátkai; László Offertáler; Fanny Mo; Jie Liu; Jan Karcher; Judith Harvey-White
    The quest for a vascular endothelial cannabinoid receptor.
    Chemistry and physics of lipids 2002;121(1-2):45-56.
  • 2002: Richard D Bukoski; Sándor Bátkai; Zoltán Járai; Yanlin Wang; Laszlo Offertaler; William F Jackson; George Kunos
    CB(1) receptor antagonist SR141716A inhibits Ca(2+)-induced relaxation in CB(1) receptor-deficient mice.
    Hypertension 2002;39(2):251-7.
  • 2001: G Kunos; S Bátkai
    Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice.
    Neurochemical research 2001;26(8-9):1015-21.
  • 2001: J A Wagner; Z Járai; S Bátkai; G Kunos
    Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    European journal of pharmacology 2001;423(2-3):203-10.
  • 2001: S Bátkai; Z Járai; J A Wagner; S K Goparaju; K Varga; J Liu; L Wang; F Mirshahi; A D Khanolkar; A Makriyannis; et al.
    Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis.
    Nature medicine 2001;7(7):827-32.
  • 2001: B Darblade; S Batkai; E Caussé; P Gourdy; M J Fouque; J Rami; J F Arnal
    Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
    Journal of vascular research 2001;38(3):266-75.
  • 2001: G Szabó; S Bátkai; T J Dengler; S Bährle; N Stumpf; W Notmeyer; R Zimmermann; C F Vahl; S Hagl
    Systolic and diastolic properties and myocardial blood flow in the heterotopically transplanted rat heart during acute cardiac rejection.
    World journal of surgery 2001;25(5):545-52.
  • 2001: V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; et al.
    Leptin-regulated endocannabinoids are involved in maintaining food intake.
    Nature 2001;410(6830):822-5.
  • 2000: G Kunos; Z Járai; S Bátkai; S K Goparaju; E J Ishac; J Liu; L Wang; J A Wagner
    Endocannabinoids as cardiovascular modulators.
    Chemistry and physics of lipids 2000;108(1-2):159-68.
  • 2000: T Ivanics; Z Miklós; Z Ruttner; S Bátkai; D W Slaaf; R S Reneman; A Tóth; L Ligeti
    Ischemia/reperfusion-induced changes in intracellular free Ca2+ levels in rat skeletal muscle fibers--an in vivo study.
    Pflügers Archiv : European journal of physiology 2000;440(2):302-8.
  • 1999: S Bátkai; I B Rácz; T Ivanics; A Tóth; J Hamar; D W Slaaf; R S Reneman; L Ligeti
    An in vivo model for studying the dynamics of intracellular free calcium changes in slow- and fast-twitch muscle fibres.
    Pflügers Archiv : European journal of physiology 1999;438(5):665-70.
  • 1998: G Szabó; S Bährle; S Bátkai; N Stumpf; T J Dengler; R Zimmermann; C F Vahl; S Hagl
    L-arginine: effect on reperfusion injury after heart transplantation.
    World journal of surgery 1998;22(8):791-7; discussion 797-8.
  • 1998: G Szabó; S Bátkai; S Bährle; T J Dengler; C F Vahl; R Zimmermann; S Hagl
    Effects of nitric oxide synthesis on reperfusion injury and catecholamine responsiveness in a heterotopic rat heart-transplantation model.
    Journal of cardiovascular pharmacology 1998;31(2):221-30.
  • 1997: C P Tiefenbacher; A Tweddell; S Batkai; R Zimmermann; H Tillmanns; W Kübler
    Endothelin does not contribute to the attenuation in myocardial function and blood flow after repetitive ischemia in the rat heart.
    Journal of vascular research 1997;34(6):447-54.
  • 1997: C P Tiefenbacher; M Ebert; F Niroomand; S Batkai; H Tillmanns; R Zimmermann; W Kübler
    Inhibition of elastase improves myocardial function after repetitive ischaemia and myocardial infarction in the rat heart.
    Pflügers Archiv : European journal of physiology 1997;433(5):563-70.
Register to see more